Market Overview

UPDATE: Jefferies Raises PT to $65 on CME Group on Long-Term Outlook

Share:
Related CME
Alexion, JetBlue, Sothebys: Fast Money Picks For November 21
Benzinga's Top Downgrades
CME declares $3.25 dividend (Seeking Alpha)

Jefferies reiterated its Buy rating on CME Group (NASDAQ: CME) and raised its price target from $60 to $65.

Jefferies noted, "Last week we spent several days with the management team of CME Group. The focus of the meetings centered around OTC clearing and execution initiatives and the globalization of CME's products, all of which represent potential offsets to the current lackluster environment for trading. On a longer-term basis we see several structural changes that should drive accelerating growth at CME."

CME Group closed at $57.29 on Friday.

Latest Ratings for CME

DateFirmActionFromTo
Nov 2016JP MorganDowngradesOverweightNeutral
Oct 2016Deutsche BankMaintainsBuy
Aug 2016JefferiesMaintainsBuy

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (CME)

View Comments and Join the Discussion!